Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$29,931,479
+$3,401,075 QoQ
Shares Held
253,206
+20.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.36178195533265.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6382180446673644.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $133,569,034 across 49 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
5,103,509 | $51,086,123 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
282,097 | $37,163,457 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
253,206 | $29,931,479 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $8,351,039 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
64,920 | $1,553,534 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,562 | $926,232 | |
| 7 | VTRS |
Viatris Inc
|
59,826 | $808,247 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
47,612 | $659,425 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,931,479 | 253,206 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $26,530,404 | 210,860 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $43,225,854 | 295,420 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,509,254 | 548,312 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $87,163,568 | 529,387 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $79,372,326 | 487,156 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $89,821,850 | 459,729 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $77,556,234 | 447,371 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $68,576,243 | 405,273 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $68,833,970 | 348,756 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $57,199,751 | 328,772 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,064,076 | 302,329 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $52,085,566 | 312,939 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $36,014,660 | 245,750 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $36,635,783 | 247,055 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $37,331,412 | 217,182 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $32,862,372 | 174,253 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $40,211,507 | 164,781 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $29,171,281 | 150,259 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,224,011 | 135,351 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $18,833,977 | 119,596 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $13,026,339 | 78,709 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,628,826 | 64,273 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,621,890 | 55,618 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,164,013 | 52,375 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||